The recent edition amplifies demand revenue for compression therapy, achieving an estimated USD 3,371.70 million in 2024. Projections infer an encouraging trajectory for the compression therapy market, potentially reaching USD 5,925.20 million by 2034. This growth trajectory shows a moderate CAGR of 5.80% through 2034.
Noteworthy parameters propelling the market growth include the climbing cost of sports injuries and auto accidents, technical breakthroughs in wound care, and the expansion of proactive treatments and rehabilitation programs.
Attributes | Details |
---|---|
Market Value for 2024 | USD 3,371.70 million |
Market Value for 2034 | USD 5,925.20 million |
Market CAGR from 2024 to 2034 | 5.80% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The weight of obese people pressurizes their skin and internal organs, bolstering their risk of suffering from vascular illnesses.
The World Health Organization said that since 1980, the universality of obesity has surged and has doubled. According to the WHO, more than 1.9 billion persons of age above 18 years or older were found to be overweight, with over 600 million of them being obese. It was later studied and found that in 2016, more than 35% of the population was obese.
Throughout the projection period, this figure is set to ascend. To hinder the path of vascular illnesses and the acceleration in the obese population, the consumption of compression therapy devices needs to be amplified.
Attributes | Details |
---|---|
Market Value for 2019 | USD 2,465.40 million |
Market Value for 2023 | USD 3,188.30 million |
Market CAGR from 2019 to 2023 | 5.30% |
The segmented compression therapy market analysis is included in the following subsection. Based on comprehensive studies, the static compression therapy sector governs the product type category. Similarly, the chronic ulcers sector is supervising the indication category.
Segment | Static Compression Therapy |
---|---|
Share (2024) | 91.10% |
The simplicity and effectiveness make static compression therapy a preferred alternative among healthcare providers for preventive and therapeutic concerns. With proven effectiveness in enhancing blood circulation and minimizing swelling, static compression therapies cater to an array of patient requirements.
The amplifying concentration on non-invasive treatment choices escalates the demand for the static compression treatment sector. As healthcare trends stress the comfort of the patients, the user-friendly attribute of static compression therapies ushers its pre-eminence.
Segment | Chronic Ulcers |
---|---|
Share (2024) | 68.30% |
The heightening prevalence of chronic disorders like diabetes and vascular diseases thrust the demand for effective ulcer treatment solutions. Chronic ulcers, like venous leg ulcers and diabetic foot ulcers, compel continuous treatment, catering to the demand for compression therapy products.
Healthcare providers recognize the significance of compression treatment in constraining ulcer reappearance, and intensifying the market growth. Emphasizing cutting down healthcare costs and enhancing patient results, concentrating on the productive management of chronic ulcers augments the demand for compression therapies.
The compression therapy market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for compression treatments.
Sales Analysis of Compression Therapy in North America
Countries | CAGR (2024 to 2034) |
---|---|
United States | 5.70% |
Canada | 6.70% |
Mexico | 4.30% |
The market proliferates due to staunching healthcare costs and escalating consumer knowledge of therapeutic compression boons. Compression therapy product technical progressions are shooting up market expansion in the United States.
The heightening prevalence of chronic sicknesses like diabetes and obesity is widening the demand for compression therapies in the United States. The adoption of compression therapy is elevating in the United States owing to attributes like the aging population and an ascend in venous disorders.
The Canadian market is blossoming owing to the government strategies and activities that encourage wellness and health. The market is augmented in Canada by the adoption of these therapies as a preventive measure against deep vein thrombosis (DVT) disorder.
Canada therapeutic compression manufacturers eye opportunities as healthcare infrastructure and institutions proliferate. The public's intensifying consciousness of the benefits of compression therapies supplements the Canada market expansion.
Opportunities for the Compression Treatment Sector in Europe
Countries | CAGR (2024 to 2034) |
---|---|
United Kingdom | 6.50% |
France | 6.10% |
Italy | 5.60% |
Spain | 5.20% |
Germany | 4.70% |
In remote regions of the United Kingdom, telemedicine infrastructures and e-commerce websites are rendering compression treatment items more accessible. The accelerated importance of patient education programs and preventive healthcare activities positively impacts compression therapy adoption in the United Kingdom. The United Kingdom market noticed a boom in the production of long-lasting and comfortable compression apparel prompted by advancements in material technology.
The compression treatment market in France is experiencing a swell in innovative technology, such as pneumatic compression pumps. Compression therapy adoption is shooting up in France because of the strengthening healthcare infrastructure and lucrative payment guidelines.
Opportunities in the Asia Pacific Compression Therapy Industry
Countries | CAGR (2024 to 2034) |
---|---|
China | 7.70% |
Japan | 5.10% |
The compression treatment market expansion in China is accelerated in large part by the strengthened accessibility of these items because of e-commerce platforms. The demand for management solutions is thrust by the prevalence of chronic diseases in China, which in turn amplifies the demand for compression treatment. The aging population and government offering spurring health awareness are the main reasons behind the growth of compression therapy in China.
The surging number of Japanese people suffering from deep vein thrombosis (DVT) and venous diseases is pushing up demand for compression treatment devices. Compression therapy is finding broader applications as it is amalgamated into post-operative care and sports injury recovery units. The compression treatment sales in Japan are inflated by the aging population and booming healthcare costs, which upturn the requirement for efficient treatment alternatives.
Large compression therapy vendors invest heavily in research and development to diversify their product ranges, which powers market expansion. Therapeutic compression manufacturers implement several strategic approaches to evolve their global footprints, including new product introductions, agreements, mergers and acquisitions, higher capital expenses, and joint ventures.
The compression treatment producers provide affordable products to develop and flourish in a more competitive and advancing market. Manufacturing regionally to save operational costs is one of the main business techniques manufacturers use worldwide compression treatment to aid customers and intensify the market. Groundbreaking Innovations and Discoveries
Company | Bauerfeind AG |
---|---|
Headquarter | Germany |
Recent Advancement |
|
Company | Medtronic plc |
---|---|
Headquarter | Ireland, Europe |
Recent Progression |
|
Company | DJO Global Inc. |
---|---|
Headquarter | United States |
Recent Advances |
|
Company | Koya Medical |
---|---|
Headquarter | United States |
Recent Progression |
|
Company | Therabody |
---|---|
Headquarter | United States |
Recent Breakthrough |
|
Company | Stryker |
---|---|
Headquarter | Michigan, United States |
Recent Progression |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The compression treatment market to cultivate a valuation of US$ 3,371.70 million in 2024.
The therapeutic compression market has the proficiency to accumulate a worth of US$ 5,925.20 million by 2034.
The compression treatment market corresponds to a moderate growth prospect of 5.80% through 2034.
From 2019 to 2023, the therapeutic compression market accelerated at an average HCAGR of 5.30%.
The static compression therapy sector is set to command a global market share of 91.10% in 2024.
The chronic ulcers segment is to retain a global market share of 68.30% in 2024.
Explore Healthcare Insights
View Reports